view more

Company Formation, Business Development, Fundraising and Consulting with a Global Perspective

Biotech  -  Pharma  -  Medtech
What we can do for you
 

Consulting Services

We provide experience-based consulting services for Biotech, Pharma and Medtech clients globally. Technical consulting, project management, strategy and management consulting, market and opportunity analyses are some of our core areas of expertise.

go

Company Creation

Ventac Partners has a global network of Life Science investors in Europe, US and Asia as well as expertise in founding and growing companies on behalf of clients. Unlike other consulting agencies, we also found, actively manage, grow and help exit innovative Portfolio Companies co-owned with partners & investors.

go

Corporate Development

We offer extensive buy and sell-side transaction experience with a truly international reach in virtually all Life Science sectors. Our specialties include in- and out-licensing, mergers & acquisitions, business development and marketing collaborations in all continents.

go
  • 03.2016

    Miacom Diagnostics, a Ventac Partners portfolio company, announces a new partnership with MetaSystems, an industry leading company in computerized imaging. For more information, please download the corresponding press release here.

  • 02.2016

    RhoVac, a Ventac Partners portfolio company, receives subscriptions for USD 17 million in preparation of its listing on the Swedish stock exchange AktieTorget. First day of trading has been set for March 9, 2016. For more information, please visit www.rhovac.com (in Swedish).

  • 02.2016

    Idogen, a Ventac Partners portfolio company, published year-end report for the period January to December 2015, see www.idogen.se for more details.

  • 05.2016

    Several Ventac Partners (K. Alevizopoulos, N. Thomas, M. Oerum, C. Velez, S. Woodward) will be participating at the 2016 BIO International Convention, June 6-9, San Francisco, CA.

  • 05.2016

    Ventac Partner portfolio companies APIM Therapeutics and Avexxin will be participating at the BioEquity Europe 2016 Forum (May 10-11, 2016, Copenhagen, Denmark).

  • 02.2016

    Ventac Partner portfolio companies APIM Therapeutics and Avexxin will be participating at the 9th Annual European Life Science CEO Forum (March 15-16, 2016, Zurich, Switzerland).

  • 12.2015

    The journal Kemivärlden Biotech features an article on Ventac portfolio company, Idogen, highlighting the company’s work on the development of tolerogenic vaccines. To read the article (in Swedish), please follow this link.

  • 12.2015

    Several partners will attend the Biotech Showcase vis-à-vis JP Morgan conference in San Francisco in January 2016.

Subscribe to our Newsletter

Thank you!